Antihistamines OTC Switch Battle Moves To Capitol Hill
This article was originally published in The Tan Sheet
Executive Summary
A House subcommittee will examine FDA's legal authority to initiate an Rx-to-OTC switch without the sponsor's consent during a June 13 hearing.